- Reyvow is Eli Lilly’s second migraine drug approved this year. It is a complementary therapy to the drugmakers other migraine drug, Emgality, and was shown to relieve migraine symptoms within two hours.
- Scenesse is an implant that goes under the skin. It is the first FDA-approved treatment for erythropoietic protoporphyria, a rare skin disorder that causes pain when exposed to sunlight.
- Fasenra, AstraZenaca’s asthma drug that was originally approved in 2017, received approval to be self-administered. It comes as a prefilled, single-use autoinjector and is now the third respiratory biologic with the option to be self-administered.
- Descovy is the second drug approved to prevent HIV. It is a daily pre-exposure prophylaxis treatment that caused controversy because it wasn’t approved for women.
More articles on pharmacy:
Novant Health to open health clinics inside Walgreens
GlaxoSmithKline recalls prescription heartburn drug globally
BIO CEO to step down at the end of 2020
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
